1 World Health Organization. Chronic respiratory diseases, Asthma. www.who.int/respiratory/asthma/en/.
2 World Health Organization. Chronic respiratory diseases., burden of COPD. www.who.int/respiratory/copd/burden/en/index.html.
3 World Health Organization. Chronic respiratory diseases.
www.who.int/gard/publications/chronic_respiratory_diseases.pdf.
4 World Health Organization. Global tuberculosis report 2016.
www.who.int/tb/publications/global_report/en/.
5 Martinez-Lozano Sinues P, Kohler M, Zenobi R. Human breath analysis may support the existence of individual metabolic phenotypes. PLoS One. 2013;8(4):e59909.
6 Sinues PM, Kohler M, Zenobi R. Monitoring diurnal changes in exhaled human breath. Anal Chem. 2013;85(1):369–73.
7 Martinez-Lozano Sinues P, Meier L, Berchtold C, Ivanov M, Sievi N, Camen G, et al. Breath analysis in real time by mass spectrometry in chronic obstructive pulmonary disease. Respiration. 2014;87(4):301–10.
8 Schwarz EI, Martinez-Lozano Sinues P, Bregy L, Gaisl T, Garcia Gomez D, Gaugg MT, et al. Effects of CPAP therapy withdrawal on exhaled breath pattern in obstructive sleep apnoea. Thorax. 2016;71(2):110–7.
9 Martinez-Lozano Sinues P. Zenobi R, Kohler M. Analysis of the Exhalome. A diagnostic tool of the future. Chest. 2013;144:746–9.
10 Bleecker ER, FitzGerald JM, Chanez P, Papi A, Weinstein SF, Barker P, et al.; SIROCCO study investigators. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial. Lancet. 2016;388(10056):2115–27.
11 Gross NJ, Barnes PJ. New therapies for Asthma and COPD. Am J Respir Crit Care Med. 2017;195(2):159–66.
DOI: 10.1164/rccm.201610-2074PP.
12 Edwards BA, Landry S, Joosten SA, Hamilton GS. Personalized medicine for obstructive sleep apnea therapies: are we there yet? Sleep Med Clin. 2016;11(3):299–311.